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Although  the  unitarian  theory  of  antibodies  has  gained  general 
acceptance since its formulation by Zinsser and others  (1), quantita- 
tive evidence for the identity of agglutinins and precipitins has been 
lacking.  Zinsser (2)  has attempted  to reconcile mathematically the 
apparent discrepancy between the serum dilutions in which agglutina- 
tion and precipitation occur and Jones  (3)  has shown that collodion 
particles coated with egg albumin are agglutinated by small quantifies 
of  anti-egg  albumin  serum.  Antibody  concentrates,  purified  by 
Felton and Bailey (4), have been found to contain precipifins, agglu- 
tinins, opsonins, and protective antibody, but quantitative data were 
lacking until after the writers' preliminary report (5). 
The development of quantitative micro methods for the estimation 
of precipitins  (6,  7)  and agglutinins (8)  has now made it possible to 
investigate the quantitative  correspondence  of precipitin and agglu- 
finin. 
Pneumococcus Type I  specific polysaccharide (acetyl form)  (9), I a  Chamber- 
land filtrate of an autolyzed 8 day Type I  Pneumococcus culture, Pneumococcus 
* The work reported in this communication was carried out under the Harkness 
Research Fund of the Presbyterian Hospital, New York.  Submitted by Mr.  E1- 
vin A. Kabat in partial fulfilment of the requirements for the  degree of Doctor 
of Philosophy, in the Faculty of Pure Science, Columbia University. 
1 A preparation of Type I  pneumococcus specific  polysaccharide in which the 
use of heat  was avoided  (9 b)  precipitated  the  same  amount  of antibody from 
horse antibody solution B 78 as did the original broth filtrate or material prepared 
according to (9 a). 
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I  S  (Dawson  M  (10))  and  R  (Dawson  S)  strains,  and  Type I  antipneumo- 
coccus sera  were  chosen as  the  objects  of study.  Serum H  701,  which was  a 
combined Pneumococcus I, II antiserum, was precipitated with a slight excess of 
Type II polysaccharide in order to leave only the Type I anticarbohydrate (cf. 8). 
To make the system approach as nearly as possible that of a  single type specific 
hapten and its  homologous antibody, the other sera were absorbed with C poly- 
saccharide and protein derived from Type I  R  pneumococci.  These  sera  still 
contained considerable amounts of group specific antibody (5), but it was found 
possible to prepare solutions containing antibody only to the type specific carbo- 
hydrate by repeated absorption with large amounts of Pneumococcus I  R  sus- 
pensiou. 
Before using the Pneumococcus I  R  strain it was necessary to know whether 
it contained residual traces of type specific carbohydrate since it was to be used 
both for the determination of anti-R in the sera, and for the removal of the anti-R 
by absorption of the sera.  That the method used was applicable was shown by a 
similar study of a Type III R strain, in which specific polysaccharide was actually 
present. 
EXPERT?~fENTAL 
The precipitin determinations were carried out by addition of known amounts 
of Type I pneumococcus specific polysaccharide to accurately measured quantities 
of absorbed serum or antibody solution and determination of the specifically pre- 
cipitated nitrogen after 48 hours at 0 ° on the washed precipitates by the micro 
Kjeldahl method (6,  7, 11).  Agglutinin determinations were made similarly (8), 
using measured volumes of washed pneumococcus suspensions and estimating the 
increase in nitrogen content.  Heat-killed suspensions were used for all analyses, 
but formalinized suspensions were also used in absorbing sera.  All determina- 
tions were run in duplicate at 0 ° for 48 hours in order to remove antibody as 
completely as possible (11). 
1.  Absence of Type Specific  Polysaccharide in a Pneumococcus  I  R  Strain.-- 
The Pneumococcus I  R  strain  used  2 (strain  1-192  R  (12))  had  been degraded 
from a  virulent Type I  S  strain  (strain  1-230  S)  which  was  also  used  in  all 
agglutinations  with  S  organisms.  It was assumed  that  if  the  I  R  suspension 
contained  type specific substance it  should remove all of the antibody from a 
type specific antiserum in a series of absorptions.  The data in Table II on sera 
H  610, H  701, and antibody solution B  76 show that no antibody was taken out 
after the initial absorption.  Since the limits of error of the quantitative agglu- 
tinin method are about  4- 0.02 nag. of nitrogen and it was also found that 0.01 
mg. of specific polysaccharide removed about 0.20 rag. of antibody nitrogen from 
antibody solution B  76, 0.02 rag. of antibody nitrogen would thus correspond to 
0.001  rag. of specific polysaccharide.  The amount of I  R  (Dawson S)  suspen- 
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sion used was 2 ml., containing about 0.44 rag. of bacterial nitrogen or approxi- 
mately 44 billion organisms)  This amount  of suspension, therefore, contained 
no  more  than  0.001  nag.  of  specific polysaccharide.  Similarly with  a  larger 
quantity of the same  suspension and  the stronger serum H  610,  0.66  rag.  of 
bacterial  nitrogen  or  approximately  66  billion organisms contained less than 
0.001  rag. of type specific substance (Table I). 
TABLE  I 
A bsorption of Agglutinins from Horse and Rabbit Antisera with Pneumococcus I  R, 
III R, and III S Suspensions 
Absorption 
No. 
1.0 ml. H 610  4.5 nil. H 53300  1.0 ml. R 3484 rabbit serum 
horse serum  horse serum 
Agglutinin  N 
removed  by 
IR 
mg. 
0.16 
0.00 
Agglutinin  N 
removed by III R* 
mg. 
0.14 
0.08 
0.06 
0.06 
0.05 
0.05 
0.04 
Absorption dis- 
continued 
Aliquot of 1st su- 
pematant 
Aliquot of 2nd su- 
pernatant 
Total agglutinin N 
Agglutinin  N removed  by 
III R  III S  I  --.]  -- 
0.098  0.176 
0.07  0.022 
0.014 
0.182  0.198 
In absorptions 2 to 7 on serum H  53300  the entire supernatant from the pre- 
ceding  absorption  was  used. 
* Centrifuged sediment  from  2.0  ml.  suspension.  Agglutinin  N  determina- 
tions with III R  and III S suspensions gave 0.56 and 0.54 rag. N  per ml., re- 
spectively. 
In order to remove the group  specific antibody,  12  ml.  of antibody solution 
B  76  were repeatedly absorbed with Pneumococcus  I  R  organisms  (about  3.5 
rag.  N  per  absorption).  The  pneumococci  were  first  centrifuged,  the super- 
natant was poured off, and  the antibody solution was added  to  the  bacterial 
sediment, taking care to obtain an even suspension.  After 24 or 48 hours the 
3 The number of organisms was determined by comparison with a suspension of 
pneumococci standardized by counting.  The numerical correspondence  of  bac- 
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agglutinated bacteria were centrifuged off and the supernatant was poured onto 
another  portion  of  centrifuged  organisms.  In  this  way  undue  dilution  was 
avoided.  After about 12 absorptions, a  determination of the anti-R on  1.0 ml. 
samples of the supernatant showed 0.016 rag. N  per ml., and since this was within 
the limit of error of the determination (8) and equalled only 1.3 per cent of the 
type specific anticarbohydrate still present, absorption was discontinued.  In the 
preparation of a large quantity of serum or of Felton antibody solution (13)  free 
from group specific antibody it is convenient to divide the material into 12 to 15 
ml. portions and absorb repeatedly with I R organisms as described for B  76. 
2.  Presence of Type Specific Polysaccharide in a Pneumococcus 111 R Strain.- 
In a  similar manner it was found that a  III R  strain  2 (MIII  R  (12)) actually 
contained a  small amount of Type III specific polysaccharide.  It will be seen 
from Table I  that on repeated absorption of a  Type III S antiserum, H  53300, 
with  the suspension,  small amounts  of  antibody nitrogen were  continually re- 
moved  and  a  limit was  not  reached.  On determining the total agglutinin in a 
smaller amount of a weaker serum, R 3484, with both Type III S and R  suspen- 
sions  (Table I), it was found that  the same total amount  of antibody nitrogen 
was ultimately removed by both strains.  These results were interpreted on  the 
basis that the Type III R  strain contained a small amount of specific polysaccha- 
ride and this was confirmed as follows: 
To 5.0 ml. of the bacterial suspension in saline 2.6 ml. of normal sodium hy- 
droxide were added and the mixture was allowed to stand at 37 ° for 72 hours. 
The solution was neutralized to phenol red with hydrochloric acid, and was made 
up to 25.0  ml. and centrifuged free from traces of insoluble material.  The salt 
concentration was then about 0.9 per cent.  3 ml. of this solution were set up with 
1.0 ml. of  a  calibrated antibody solution (14)  and the suspension was found to 
contain 0.0154 mg. of type specific polysaccharide per rag. of bacterial nitrogen-- 
an appreciable amount. 
Two different lots of the Type I S suspension used were found by this method to 
contain 0.462  and 0.493  rag. of type specific polysaccharide per rag. of bacterial 
nitrogen.  The analyses were made as in the case of the Type III suspension ex- 
cept that the Type I  polysaccharide used in calibrating the serum was treated 
with alkali at 37 ° for 72 hours in the same way as the bacterial suspension of which 
the  polysaccharide content  was  to  be  determined,  since Avery and Goebel (9) 
have shown that alkali treatment decreases the precipitating power of the poly- 
saccharide. 
3.  Identity of A gglutlnin and Precipitin.--In  Table II are given the precipitin 
and  agglutinin  determinations.  As  will  be  noted,  total  agglutinin  and  total 
precipitin estimations were run, and in other instances a portion of the precipitin 
or agglutiuin was removed and the agglutinin or precipitin in the supernatant was 
determined.  In the last column are given the values for total antibody found, 
either for total agglutinin or precipitin alone, or for the sum of the analytical 
values for agglutinin plus precipitin.  Serum H  610 and antibody solution B  76 
were  the  same  as  those  used  in  the  first  paper  of  this series (8), except that MICHAEL  HEIDELBERGEI~  AND  ELVIN  A.  KABAT  741 
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B 76 was somewhat more concentrated.  "B 76 absorbed" and B 78 are the anti- 
body solutions from which practically all of the group specific antibody was re- 
moved as described above.  H 701 was a New York City Department of Health 
Type I, II mixed antipneumococcus serum from which the Type II antibody had 
been removed.  The data for antibody solution B 75 have already been presented 
in the preliminary note (5) and are therefore not repeated: 
The Type I specific polysaccharide  used contained a small amount of C sub- 
stance 05), so that I R agglutinin values were smaller after removal of precipitin. 
In the experiments on the partial removal of agglutinin and precipitin, a known 
volume of bacterial  suspension  (or of polysaccharide  solution)  was added to a 
measured volume of serum or antibody solution, and after removal and analysis of 
the precipitate (6-8),  an aliquot portion of the supematant was set up with an- 
other  measured  volume  of  polysaccharide  solution  (or  bacterial  suspension). 
Finally, an aliquot of this second supernatant was set up with a known volume of 
Pneumococcus I S suspension in order to remove any traces of antibody remaining. 
The values in the table are corrected for the aliquots taken. 
DISCUSSION 
In order  to determine whether or not precipitin  and agglutinin  are 
identical it was desirable to limit the investigation as nearly as pos- 
sible  to a  single type specific antigen or hapten and its homologous 
antibody.  However,  pneumococci  contain  group  specific  antigens, 
and  antipneumococcus  sera  may  show  varying  amounts  of  group 
specific as well as type specific antibodies.  It was therefore essential 
to have available a  strain free from type specific antigen both for the 
purpose of estimating quantitatively the group specific antibody in a 
serum and for absorption of group specific antibody from such sera. 
Owing to the large number of absorptions necessary, the presence of 
even  small amounts of type specific polysaccharide would result  in 
removal of much of the antibody it was desired to retain. 
The application of the quantitative agglutinin method (8)  to estab- 
lish  the  presence  or  absence  of  an  antigenic  component  in  the  R 
strains  used  is  illustrated  in  the  section  on  experiments  and  sum- 
marized  in  Table  I.  It  may be  noted  that  Dawson  (16)  found  it 
possible to cause reversion of the Pneumococcus MIII  R strain  (which 
contains specific polysaccharide) to the S variant by in vitro as well as 
in vivo methods, whereas the 1-192  R  strain (which is free from specific 
polysaccharide) was exceedingly stable and could only be converted 
into  the  S  form by  subcutaneous  injection  with I  S  vaccine.  The MICHAEL HEIDELBERGER  AND ELVIN A. KABAT  743 
analytical method given should therefore be of service in indicating 
the completeness of dissociation and possibly the stability of variants. 
Data  regarding  the  identity  of  agglutinins  and  precipitins  are 
summarized in  Table  II.  In  the  Type  I  antipneumococcus horse 
sera H 610 and H  701 it will be seen that type specific precipitin plus 
the small amount of residual group specific  agglutinin equals  total 
agglutinin, and that total antibody nitrogen remains the same when 
only  a  portion  of  the  type specific  antibody  (anticarbohydrate)  is 
first removed either as agglutinin or precipitin and the remainder as 
precipitin or agglutinin.  Since the value for total antibody nitrogen 
in the combined precipitin-agglutinin estimations is the result of three 
independent sets of analyses, each involving several successive deter- 
minations, the precision attained is not as great as in the estimation 
solely of total agglutinin or total precipitin.  The difference between 
the extreme values in the various sera ranges from 3.5 to 8.5 per cent 
of the total antibody content. 
The data for sera H 610 and H  701 indicate the quantitative corre- 
spondence  of  the  type  specific  anticarbohydrate  agglutinin  and 
precipitin within the limits of accuracy of the method.  Using the 
mean values for total antibody nitrogen, antibody solution B 76, both 
unabsorbed and absorbed, yielded about 11.5 per cent more agglutinin 
nitrogen than precipitin nitrogen, while solution B 78 showed only a 4 
per cent excess of type specific agglutinin.  Since serum H  610, from 
which solution B  76 was prepared, did not show this effect, it would 
appear that a portion of the antibody had been slightly altered in the 
process of purification, a possibility already considered by Felton (13). 
While the data for total type specific agglutinin and precipitin show 
the same quantity of each form of antibody it would still be possible 
that different substances, present in equal quantity, were involved. 
This possibility is  eliminated, however, by  the  experiments on  the 
partial removal of precipitin and agglutinin (Table II), since such a 
reduction  of  the  content  of  precipitin  or  agglutinin  resulted  in 
an  equal  reduction  of  the  amount  of  agglutinin  or  precipitin, 
respectively, remaining in the solution.  Evidence is  thus given for 
the  identity of  the  type  specific  anticarbohydrate  agglutinin  and 
precipitin in these sera. 744  BACTERIAL AGGLUTINATION.  II 
SUMM.ARY 
1.  The absolute, quantitative agglutinin method has been used for 
the determination of  the presence or  absence  of small  amounts  of 
specific polysaccharlde in pneumococcus variants. 
2.  A  technique is described for the removal of group specific anti- 
body from antipneumococcus horse serum. 
3.  The  type  specific  anticarbohydrate  agglutinin  and  precipltin 
are not only present in identical amounts in Type I antipneumococcus 
horse serum, but a reduction in one is also accompanied by a quanti- 
tatively identical reduction in the other, providing evidence for their 
actual identity.  In purified antibody solutions somewhat more agglu- 
tinin than precipitin is found, possibly owing to alteration of a portion 
of the antibody in the process of purification. 
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